| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |